Mitochondria Are Direct Targets of the Lipoxygenase Inhibitor MK886
We have investigated the mitochondrial and cellular effects of the lipoxygenase inhibitor MK886. Low concentrations (1 μ m ) of MK886 selectively sensitized the permeability transition pore (PTP) to opening, whereas higher concentrations of MK886 (10 μ m ) caused depolarization through combination...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2002-08, Vol.277 (35), p.31789-31795 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We have investigated the mitochondrial and cellular effects of the lipoxygenase inhibitor MK886. Low concentrations (1 μ m ) of MK886 selectively sensitized the permeability transition pore (PTP) to opening, whereas higher concentrations of MK886
(10 μ m ) caused depolarization through combination of an ionophoretic effect with inhibition of respiration. MK886 killed prostate
cancer PC3 cells only at the higher, toxic concentration (10 μ m ), whereas the lower concentration (1 μ m ) had no major effect on cell survival. However, 1 μ m MK886 alone demonstrably induced PTP-dependent mitochondrial dysfunction; and it caused cell death through the mitochondrial
pathway when it was used in combination with the cyclooxygenase inhibitor, indomethacin, which had no effects per se . Treatment with 1 μ m MK886 plus indomethacin sensitized cells to killing by exogenous arachidonic acid, which induces PTP opening and cytochrome
c release (Scorrano, L., Penzo, D., Petronilli, V., Pagano, F., and Bernardi, P. (2001) J. Biol. Chem. 276, 12035â12040). Combination of MK886 and cyclooxygenase inhibitors may represent a viable therapeutic strategy to force
cell death through the mitochondrial pathway. This approach should be specifically useful to kill cells possessing a high
flux of arachidonic acid and its metabolites like prostate and colon cancer cells. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M204450200 |